| ASBP | INTS | ASBP / INTS | |
| Capitalization | 12.7M | 13.3M | 95% |
| EBITDA | -1.74M | -11.48M | 15% |
| Gain YTD | -94.276 | -60.800 | 155% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 97.7K | 0 | - |
| Total Cash | 12.2M | 9.53M | 128% |
| Total Debt | N/A | 95K | - |
| ASBP | INTS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 26% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 27% | 2 days ago 65% |
| Momentum ODDS (%) | N/A | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 35% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 55% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 43% | 2 days ago 90% |
| Advances ODDS (%) | 10 days ago 52% | 26 days ago 68% |
| Declines ODDS (%) | 4 days ago 81% | 4 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 35% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 33% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASBP’s FA Score shows that 1 FA rating(s) are green while INTS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASBP’s TA Score shows that 2 TA indicator(s) are bullish while INTS’s TA Score has 2 bullish TA indicator(s).
ASBP (@Auto Parts: OEM) experienced а +2.14% price change this week, while INTS (@Biotechnology) price change was -1.95% for the same time period.
The average weekly price growth across all stocks in the @Auto Parts: OEM industry was -4.25%. For the same industry, the average monthly price growth was -3.01%, and the average quarterly price growth was +5.48%.
The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.
INTS is expected to report earnings on Nov 17, 2026.
OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.
@Biotechnology (-6.09% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.
| Ticker / NAME | Correlation To ASBP | 1D Price Change % | ||
|---|---|---|---|---|
| ASBP | 100% | -0.66% | ||
| SPRO - ASBP | 42% Loosely correlated | +0.89% | ||
| ALZN - ASBP | 38% Loosely correlated | +1.18% | ||
| DCOY - ASBP | 31% Poorly correlated | -1.47% | ||
| CMPX - ASBP | 28% Poorly correlated | -2.44% | ||
| INTS - ASBP | 27% Poorly correlated | -0.50% | ||
More | ||||
A.I.dvisor tells us that INTS and ACAD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and ACAD's prices will move in lockstep.
| Ticker / NAME | Correlation To INTS | 1D Price Change % | ||
|---|---|---|---|---|
| INTS | 100% | -0.50% | ||
| ACAD - INTS | 28% Poorly correlated | +0.32% | ||
| ASBP - INTS | 27% Poorly correlated | -0.66% | ||
| CCCC - INTS | 27% Poorly correlated | +3.24% | ||
| IMVT - INTS | 27% Poorly correlated | -1.94% | ||
| ADXN - INTS | 26% Poorly correlated | +2.95% | ||
More | ||||